5-HYDROXY-N-METHYLPYRIDINE-2-CARBOXAMIDE, 95.0%, 250mg

Tetrahydrofurfuryl Acrylate (stabilized with MEHQ)>98.0%(GC)25g

(2S,4S)-2,4-Bis(diphenylphosphino)pentane, 97%, 100mg

(1S,4R,E)-4-((1R,3aS,7aR,E)-4-((E)-2-((3S,5R)-3,5-bis(tert-butyldimethylsilyloxy)-2-methylenecyclohexylidene)ethylidene)-7a-methyloctahydro-1H-inden-1-yl)-1-cyclopropylpent-2-en-1-ol, 98%, 1g

Lithium Oxalate>98.0%(T)500g

N,3-dimethyl-3-piperidinecarboxamide hydrochloride, 95.0%, 10g

L-histidina, mínimo 98,5 %, Ph.Eur., para bioquímica, 1 kg, envase de plástico.

(11aS)-Dibenzo[d,f][1,3]dioxepin-1,11-diylbis[diphenylphosphine], 97%, 250mg

{[(3-chlorophenyl)methyl]sulfanyl}methanimidamide hydrobromide, 95.0%, 5g

(S)-1-(2-(TRIFLUOROMETHYL)PHENYL)ETHANOL, 95%, 5g

3A,4,7,7A-TETRAHYDRO-4-METHYL-4,7-EPOXYISOBENZOFURAN-1,3-DIONE, 95.0%, 250mg

3-(piperidin-4-yl)-1H,2H,3H,4H-pyrido[2,3-d]pyrimidine-2,4-dione dihydrochloride, 95.0%, 250mg

Tert-butyl 3-(aminomethyl)-6,7-dihydroisoxazolo[4,5-c]pyridine-5(4h)-carboxylate, 97%, 250mg